RARITAN, NJ – October 26, 2009 – iContracts, a leading provider of solutions for managing corporate contracts, commitments, and compliance today announced that Cornerstone Therapeutics Inc.®, a pharmaceutical company specializing in the respiratory and related markets, has selected solutions from iContracts™ to manage chargebacks, rebates, Medicaid, and government pricing compliance. The entire suite of products are based on iContracts’ Better Contracting Solutions (BCS) platform, available on-demand or behind-the-firewall, and will help Cornerstone Therapeutics manage these complex processes in a unified environment on an accelerated implementation timeframe. Cornerstone has opted to access all iContracts solutions as a software service over the web, thus requiring no investment in facilities, hardware, software, or related costs.
Donna Forbes White, Director of Commercial and Business Analytics, with Cornerstone Therapeutics, commented “iContracts fully integrated suite of solutions, powerful process automation and rapid implementation capability were important factors in our decision. We look forward to working with iContracts on this important project and expect to begin realizing substantial benefits quickly.”
“We are extremely excited to be working with a leader like Cornerstone Therapeutics to deliver on our promise of better contracting solutions for the pharmaceutical industry”, observed A. Leigh Powell, Chief Executive Officer of iContracts. Like many of our clients, Cornerstone had the opportunity to evaluate other solutions and concluded that only iContracts could meet their stringent requirements and rapid deployment timeframe while simultaneously automating many of the processes and decisions that would normally require far higher levels of staffing”.
iContracts solutions are available as an “on demand” service or as a behind-the-firewall offering and are built on iContracts’s revolutionary BCS platform featuring an advanced data architecture, rich functionality and Simplified Common User Interface (SCUI) enabling users to execute any process after learning just two basic screen formats. This groundbreaking design drastically reduces implementation, training and future upgrade timeframes and costs.
About iContracts
iContracts delivers solutions for managing contracts that are faster, easier and less expensive to implement. This mantra is reflected in everything we do. Our software is far ahead of other solutions. Powered by a Simplified Common User Interface (SCUI) that makes every user an “expert” by learning just two simple, reusable views and is backed by a highly evolved data architecture – built by technologists with considerable and unique experience in building contract management solutions for the Life Sciences industry. This deep understanding and straightforward approach shows in everything we do. iContracts’ comprehensive suite of solutions manages all aspects of a Life Science company’s chargeback, rebate and Medicaid processes as well as other incentive agreements and Government Pricing compliance at all levels. Our solutions are enterprise-class and can be easily integrated with any off-the-shelf or custom system to meet exacting business requirements without the army of consultants and endless fees associated with other products and providers. For more information, please visit www.icontracts.com.
About Cornerstone Therapeutics
Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets. The Company currently promotes multiple marketed products in the United States to respiratory-focused physicians and key retail pharmacies with its specialty sales force. The Company also has a late-stage clinical pipeline with a recent regulatory submission filing and four additional regulatory approval submissions targeted within the next three years. Key elements of the Company’s strategy are to in-license or acquire rights to underpromoted, patent-protected, branded respiratory or related pharmaceutical products or late-stage product candidates; implement life cycle management strategies to maximize the potential value and competitive position of the Company’s currently marketed products, newly acquired products and product candidates that are currently in development; grow product revenue through the Company’s specialty sales force, which is focused on the respiratory and related markets; and maintain and strengthen the intellectual property position of the Company’s currently marketed products, newly acquired products and product candidates.
iContracts Media Contact:
Anne Ambrosio
iContracts, Inc.
Tel: 908-393-9550
aambrosio@icontracts.com